SCHEMBL114246

SCHEMBL114246

CC(O)C(C)CCCc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
KMT2A Q03164 1/20 0.46
LMNA P02545 1/20 0.45
PKM P14618 1/20 0.45
SIGMAR1 Q99720 2/20 0.44
HDAC3 O15379 2/20 0.44
HDAC4 P56524 2/20 0.44
HDAC1 Q13547 2/20 0.44
HDAC7 Q8WUI4 2/20 0.44
HDAC2 Q92769 2/20 0.44
HDAC10 Q969S8 2/20 0.44
HDAC11 Q96DB2 2/20 0.44
HDAC8 Q9BY41 2/20 0.44
HDAC6 Q9UBN7 2/20 0.44
HDAC9 Q9UKV0 2/20 0.44
HDAC5 Q9UQL6 2/20 0.44
NPC1 O15118 1/20 0.44
CASP3 P42574 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18948459 1.00 CYP2D6 (0.46) CYP2D6CYP2C9CYP2C19KMT2ALMNA
SCHEMBL19539215 0.88 CYP2D6 (0.46) CYP2D6CYP2C9CYP2C19KMT2ALMNA
SCHEMBL27905427 0.88 TSHR (0.50) CYP2D6CYP2C19KMT2ALMNATDP1
SCHEMBL2571201 0.83 CYP2D6 (0.49) CYP2D6CYP2C9CYP2C19KMT2ALMNA
SCHEMBL560468 0.83 CYP2D6 (0.49) CYP2D6CYP2C9CYP2C19KMT2ALMNA
SCHEMBL10472566 0.83 CYP2D6 (0.49) CYP2D6CYP2C9CYP2C19KMT2ALMNA
SCHEMBL6024122 0.81 GRIK1 (0.49) CYP2D6CYP2C9CYP2C19KMT2ASIGMAR1
SCHEMBL112982 0.81 RAB9A (0.41) CYP2D6LMNAPKMSIGMAR1HDAC1
SCHEMBL18943785 0.80 PTGER4 (0.42) CYP2D6CYP2C9CYP2C19KMT2ALMNA
SCHEMBL19189064 0.79 TRPA1 (0.53) CYP2D6CYP2C9CYP2C19KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1935109-A Integration of activity matter for deodorizer BEIERSDORF AG (DE) 2007-03-28 CN claimed
US-12441953-B2 Isomer mixtures of unsaturated macrocyclic musk compounds SYMRISE AG (DE) 2025-10-14 US disclosed
EP-4624559-A2 ISOMER MIXTURES OF UNSATURATED MACROCYCLIC MUSK COMPOUNDS Symrise AG (DE) 2025-10-01 EP disclosed
EP-3898910-B1 ALICYCLIC MUSK FRAGRANCE COMPOUNDS SYMRISE AG (DE) 2025-09-03 EP disclosed
EP-3880777-B1 PERFUMING INGREDIENTS WITH LILY OF THE VALLEY NOTE SYMRISE AG (DE) 2025-06-25 EP disclosed
EP-4006130-B1 ISOMER MIXTURES OF UNSATURATED MACROCYCLIC MUSK COMPOUNDS SYMRISE AG (DE) 2025-04-09 EP disclosed
EP-4519244-A1 NOVEL FRAGRANCE COMPOUNDS Symrise AG (DE) 2025-03-12 EP disclosed
CN-112969774-B Perfuming ingredients with mugwort flavour 西姆莱斯有限公司 2025-02-14 CN disclosed
US-12110472-B2 Perfuming ingredients with lily of the valley note SYMRISE AG (DE) 2024-10-08 US disclosed
US-12031106-B2 Use of 1-ethyl-4,4-dimethyl-cyclohexane derivatives as fragrances SYMRISE AG (DE) 2024-07-09 US disclosed
EP-2424829-A2 OMEGA-CYCLOHEXYLALKAN-1-OLES AND USE THEREOF AS ANTIMICROBIAL ACTIVES TO COMBAT BODY ODOR Symrise AG (DE) 2012-03-07 EP disclosed
US-20110129432-A1 L-MENTHYL-N-(2-HYDROXYPHENYL)CARBAMATE SYMRISE AG (DE) 2011-06-02 US disclosed
EP-2307357-A1 L-MENTHYL-N-(2-HYDROXYPHENYL)CARBAMATE Symrise AG (DE) 2011-04-13 EP disclosed
EP-2133102-A1 Odor reducers Symrise GmbH & Co. KG (DE) 2009-12-16 EP disclosed
WO-2009144179-A1 L-MENTHYL-N-(2-HYDROXYPHENYL)CARBAMATE SYMRISE GMBH & CO. KG (DE) 2009-12-03 WO disclosed
US-20090238787-A1 ODOUR-REDUCING SUBSTANCES SYMRISE GMBH & CO. KG (DE) 2009-09-24 US disclosed
WO-2009101216-A2 OMEGA-CYCLOHEXYLALKAN-1-OLES AND USE THEREOF AS ANTIMICROBIAL ACTIVES TO COMBAT BODY ODOR SYMRISE GMBH & CO. KG (DE) 2009-08-20 WO disclosed
US-20090123392-A1 FRAGRANCE ACCORDS TO COMBAT THE PERCEPTION OF BODY ODOR SYMRISE GMBH & CO. KG (DE) 2009-05-14 US disclosed
EP-2014273-A1 Use of methyl methyl ether and another ether to provide a feeling of cleanliness and purity Symrise GmbH & Co. KG (DE) 2009-01-14 EP disclosed
CN-1935109-A Integration of activity matter for deodorizer BEIERSDORF AG (DE) 2007-03-28 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110129432-A1 L-MENTHYL-N-(2-HYDROXYPHENYL)CARBAMATE CRAT, LANCL1, ACAT1 CYP2D6 653/4885CYP2C9 844/4885CYP2C19 714/4885
US-12110472-B2 Perfuming ingredients with lily of the valley note PIR, ALG3, PNN CYP2D6 353/4885CYP2C9 1557/4885CYP2C19 2119/4885
US-12031106-B2 Use of 1-ethyl-4,4-dimethyl-cyclohexane derivatives as fragrances ACMSD, ETV1, HTR1D CYP2D6 746/4885CYP2C9 1557/4885CYP2C19 1768/4885
US-20090238787-A1 ODOUR-REDUCING SUBSTANCES ADH1A, ADH1C, ALDH1A1 CYP2D6 482/4885CYP2C9 1185/4885CYP2C19 1988/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.